MyMedR

Displaying all 6 publications

Abstract:

Sort:

Assessing the Economics of Dengue: Results from a Systematic Review of the Literature and Expert Survey

Constenla D, Garcia C, Lefcourt N

Pharmacoeconomics, 2015 Nov;33(11):1107-35.
PMID: 26048354 DOI: 10.1007/s40273-015-0294-7

The economics of dengue is complex and multifaceted.
Long term flow change threatens invertebrate diversity in temporary streams: Evidence from an island

Garcia C, Gibbins CN, Pardo I, Batalla RJ

Sci Total Environ, 2017 Feb 15;580:1453-1459.
PMID: 28027801 DOI: 10.1016/j.scitotenv.2016.12.119

Here we provide the first evidence of long term reductions in flow in temporary streams on the Mediterranean island of Mallorca and use a simple metric of the degree of water permanence (the number of days with water) to highlight the implications of flow change for aquatic invertebrate diversity. Analysis of a 33year data set for 13 streams on the island yielded evidence of consistent downward trends in water permanence, particularly in spring and summer. Data from 27 relatively undisturbed mountain streams indicate that the diversity of benthic invertebrates in temporary streams across the island is directly related to water permanence. Streams with lower values of water permanence support few species overall and have less abundant invertebrate assemblages; the abundance and species richness of sensitive mayfly, stonefly and caddisfly taxonomic groups is also reduced in streams with lower water permanence. Although developed using spatial data, these flow-invertebrate relationships suggest that future reductions in water permanence may lead to reduced diversity. We argue that the 'number of days with water' is a simple but ecologically-relevant metric of water permanence that can be used effectively to monitor change in threatened temporary streams worldwide.
Fulltext Insight in the quorum sensing-driven lifestyle of the non-pathogenic Agrobacterium tumefaciens 6N2 and the interactions with the yeast Meyerozyma guilliermondii

Bertini EV, Torres MA, Léger T, Garcia C, Hong KW, Chong TM, et al.

Genomics, 2021 11;113(6):4352-4360.
PMID: 34793950 DOI: 10.1016/j.ygeno.2021.11.017

Agrobacterium tumefaciens is considered a prominent phytopathogen, though most isolates are nonpathogenic. Agrobacteria can inhabit plant tissues interacting with other microorganisms. Yeasts are likewise part of these communities. We analyzed the quorum sensing (QS) systems of A. tumefaciens strain 6N2, and its relevance for the interaction with the yeast Meyerozyma guilliermondii, both sugarcane endophytes. We show that strain 6N2 is nonpathogenic, produces OHC8-HSL, OHC10-HSL, OC12-HSL and OHC12-HSL as QS signals, and possesses a complex QS architecture, with one truncated, two complete systems, and three additional QS-signal receptors. A proteomic approach showed differences in QS-regulated proteins between pure (64 proteins) and dual (33 proteins) cultures. Seven proteins were consistently regulated by quorum sensing in pure and dual cultures. M. guilliermondii proteins influenced by QS activity were also evaluated. Several up- and down- regulated proteins differed depending on the bacterial QS. These results show the QS regulation in the bacteria-yeast interactions.
Sociodemographic Correlates of Mental Health Treatment Seeking Among College Students: A Systematic Review and Meta-Analysis

Pei J, Amanvermez Y, Vigo D, Puyat J, Kessler RC, Mortier P, et al.

Psychiatr Serv, 2024 Jan 31.
PMID: 38291886 DOI: 10.1176/appi.ps.20230414

OBJECTIVE: College students have high rates of mental health problems and low rates of treatment. Although sociodemographic disparities in student mental health treatment seeking have been reported, findings have not been synthesized and quantified. The extent to which differences in perceived need for treatment contribute to overall disparities remains unclear.
METHODS: A systematic search of PubMed, PsycInfo, and Embase was conducted. Studies published between 2007 and 2022 were included if they reported treatment rates among college students with mental health problems, stratified by sex, gender, race-ethnicity, sexual orientation, student type, student year, or student status. Random-effects models were used to calculate pooled prevalence ratios (PRs) of having a perceived need for treatment and of receiving treatment for each sociodemographic subgroup.
RESULTS: Twenty-one studies qualified for inclusion. Among students experiencing mental health problems, consistent and significant sociodemographic differences were identified in perceived need for treatment and treatment receipt. Students from racial-ethnic minority groups (in particular, Asian students [PR=0.49]) and international students (PR=0.63) reported lower rates of treatment receipt than White students and domestic students, respectively. Students identifying as female (sex) or as women (gender) (combined PR=1.33) reported higher rates of treatment receipt than students identifying as male or as men. Differences in perceived need appeared to contribute to some disparities; in particular, students identifying as male or as men reported considerably lower rates of perceived need than students identifying as female or as women.
CONCLUSIONS: Findings highlight the need for policy makers to address barriers throughout the treatment-seeking pathway and to tailor efforts to student subgroups to reduce treatment disparities.
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

de Leon J, Schoretsanitis G, Smith RL, Molden E, Solismaa A, Seppälä N, et al.

Pharmacopsychiatry, 2021 Dec 15.
PMID: 34911124 DOI: 10.1055/a-1625-6388

This international guideline proposes improving clozapine package inserts worldwide by using ancestry-based dosing and titration. Adverse drug reaction (ADR) databases suggest that clozapine is the third most toxic drug in the United States (US), and it produces four times higher worldwide pneumonia mortality than that by agranulocytosis or myocarditis. For trough steady-state clozapine serum concentrations, the therapeutic reference range is narrow, from 350 to 600 ng/mL with the potential for toxicity and ADRs as concentrations increase. Clozapine is mainly metabolized by CYP1A2 (female non-smokers, the lowest dose; male smokers, the highest dose). Poor metabolizer status through phenotypic conversion is associated with co-prescription of inhibitors (including oral contraceptives and valproate), obesity, or inflammation with C-reactive protein (CRP) elevations. The Asian population (Pakistan to Japan) or the Americas' original inhabitants have lower CYP1A2 activity and require lower clozapine doses to reach concentrations of 350 ng/mL. In the US, daily doses of 300-600 mg/day are recommended. Slow personalized titration may prevent early ADRs (including syncope, myocarditis, and pneumonia). This guideline defines six personalized titration schedules for inpatients: 1) ancestry from Asia or the original people from the Americas with lower metabolism (obesity or valproate) needing minimum therapeutic dosages of 75-150 mg/day, 2) ancestry from Asia or the original people from the Americas with average metabolism needing 175-300 mg/day, 3) European/Western Asian ancestry with lower metabolism (obesity or valproate) needing 100-200 mg/day, 4) European/Western Asian ancestry with average metabolism needing 250-400 mg/day, 5) in the US with ancestries other than from Asia or the original people from the Americas with lower clozapine metabolism (obesity or valproate) needing 150-300 mg/day, and 6) in the US with ancestries other than from Asia or the original people from the Americas with average clozapine metabolism needing 300-600 mg/day. Baseline and weekly CRP monitoring for at least four weeks is required to identify any inflammation, including inflammation secondary to clozapine rapid titration.
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

de Leon J, Schoretsanitis G, Smith RL, Molden E, Solismaa A, Seppälä N, et al.

Pharmacopsychiatry, 2022 Jan 20.
PMID: 35052001 DOI: 10.1055/a-1737-1527